Koninklijke Philips N.V.
PHGHealthcareNASDAQMedical Devices · Last scanned Oct 26, 2026
Scan Results
Daily timeframeKoninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. Valued at $26.28B, PHG is a large-cap name in its sector. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments.
Market Cap
$26.28B
Beta
0.92
P/E (TTM)
20.07
P/E (Fwd)
14.20
EPS (TTM)
$1.34
EPS (Fwd)
$1.89
ROE
10.2%
ROA
4.1%
Cash
$1.79B
Total Debt
$7.46B
Free CF
$1.53B
52W Change
-6.9%
Annual Financials
Cash vs Debt
Where PHG stands vs its 150-day and 200-day moving averages
As of the October 13, 2026 close, PHG finished 5.79% below its 150-day moving average ($26.26) and 7.86% below its 200-day moving average ($26.85). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PHG overbought or oversold?
At the October 13, 2026 close, PHG's RSI(14) was 46.9, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $1.79B in cash, though total debt stands at $7.46B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $1.53B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 10.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $17.16B (2021) to $17.83B (2025).
Investors considering Koninklijke Philips N.V. should weigh the typical risks associated with PHG's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing PHG.